MALMÖ, SE / ACCESS Newswire / November 15, 2025 / Ascelia Pharma AB (publ) (ticker: ACE), a biotech focused on improving the life of people living with rare cancer conditions, today announced that the ...
The Food and Drug Administration (FDA) has issued a statement, published electronically in the New England Journal of ...
Stockhead on MSN
Singular Health seeks FDA 510(k) clearance for next-generation 3D medical-imaging and sharing platform
Singular Health has submitted a 510(k) premarket notification to the US Food and Drug Administration (FDA) for its ...
IMT Innovations is seeking an exclusive U.S. manufacturer of a next-gen ventilator design ready to start the regulatory ...
Cerus Corporation develops the Intercept Blood System for platelets, plasma, and IFC. Click here to read more about CERS ...
Baystreet.ca News Commentary – The metabolic disorder therapeutics market projects growth to $120.7 billion by 2030 as biotechnology firms pioneer organ-level treatments addressing ...
Despite the rapid invention and widespread use of artificial intelligence (AI), the federal government is just beginning to shape the ...
The ALS Network, in partnership with 12 ALS United member organizations, announces the selection of its 2025 Research Innovation Grantees?an accomplished group of scientists and clinicians whose work ...
Bildnachweis: Ignite Medical, DxPx Advisors, FCF, DiaMonTech, Pixabay, VC Magazin. German medtech and diagnostics start-ups face a number of challenges for raising seed and venture capital. Early ...
FDA proposals include ‘major updates’ to simplify biosimilarity studies, reduce unnecessary clinical testing, and ease the ...
Scholars argue that federal drug agency actions should take precedence over conflicting state regulations. How should courts handle state regulations that restrict access to pharmaceuticals previously ...
Richard Pazdur, the new director of the Center for Drug Evaluation and Research, raised concerns amid the rollout of several ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results